S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case

Zevra Therapeutics (ZVRA) Earnings Date, Estimates & Call Transcripts

$7.08
+0.34 (+5.04%)
(As of 03/1/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

ZVRA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ZVRA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Zevra Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.47)($0.47)($0.47)
Q2 20241($0.40)($0.40)($0.40)
Q3 20241($0.27)($0.27)($0.27)
Q4 20241($0.09)($0.09)($0.09)
FY 20244($1.23)($1.23)($1.23)

ZVRA Earnings Date and Information

Zevra Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 5th, 2024 based off prior year's report dates.

Zevra Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/5/2024
Estimated)
------- 
11/7/2023Q3 2023($0.29)($0.40)($0.11)($0.40)$3.70 million$2.90 million
8/14/2023Q2 2023($0.39)($0.15)+$0.24($0.15)$2.90 million$8.47 million    
5/15/2023Q1 2023($0.26)($0.34)($0.08)($0.34)$2.77 million$2.88 million  
3/7/2023Q4 2022($0.21)($0.26)($0.05)($0.26)$3.00 million$2.32 million
11/9/2022Q3 2022($0.19)($0.19)-($0.19)$2.97 million$2.87 million
8/11/2022Q2 2022($0.14)($0.19)($0.05)$0.32$1.75 million$1.30 million
5/12/2022Q1 2022($0.06)($0.06)-($0.07)$3.07 million$3.97 million
11/10/2021Q3 2021($0.08)($0.06)+$0.02($0.06)$2.15 million$1.97 million
8/12/2021Q2 2021$0.23($0.40)($0.63)($0.40)$12.10 million$11.99 million
5/13/2021Q1 2021($0.17)($1.61)($1.44)($0.73)$2.10 million$12.12 million












Zevra Therapeutics Earnings - Frequently Asked Questions

When is Zevra Therapeutics's earnings date?

Zevra Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 5th, 2024 based off last year's report dates. Learn more on ZVRA's earnings history.

How much revenue does Zevra Therapeutics generate each year?

Zevra Therapeutics (NASDAQ:ZVRA) has a recorded annual revenue of $10.46 million.

How much profit does Zevra Therapeutics generate each year?

Zevra Therapeutics (NASDAQ:ZVRA) has a recorded net income of -$41.54 million. ZVRA has generated -$1.15 earnings per share over the last four quarters.

What is Zevra Therapeutics's EPS forecast for next year?

Zevra Therapeutics's earnings are expected to grow from ($1.15) per share to ($1.03) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ZVRA) was last updated on 3/3/2024 by MarketBeat.com Staff